226 related articles for article (PubMed ID: 15761255)
1. Adenovirus vector-based vaccines for human immunodeficiency virus type 1.
Barouch DH; Nabel GJ
Hum Gene Ther; 2005 Feb; 16(2):149-56. PubMed ID: 15761255
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-based genetic vaccines for biodefense.
Boyer JL; Kobinger G; Wilson JM; Crystal RG
Hum Gene Ther; 2005 Feb; 16(2):157-68. PubMed ID: 15761256
[TBL] [Abstract][Full Text] [Related]
3. Novel adenovirus vector-based vaccines for HIV-1.
Barouch DH
Curr Opin HIV AIDS; 2010 Sep; 5(5):386-90. PubMed ID: 20978378
[TBL] [Abstract][Full Text] [Related]
4. Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D.
Abbink P; Lemckert AA; Ewald BA; Lynch DM; Denholtz M; Smits S; Holterman L; Damen I; Vogels R; Thorner AR; O'Brien KL; Carville A; Mansfield KG; Goudsmit J; Havenga MJ; Barouch DH
J Virol; 2007 May; 81(9):4654-63. PubMed ID: 17329340
[TBL] [Abstract][Full Text] [Related]
5. Use of adenovirus in vaccines for HIV.
Patterson S; Papagatsias T; Benlahrech A
Handb Exp Pharmacol; 2009; (188):275-93. PubMed ID: 19031031
[TBL] [Abstract][Full Text] [Related]
6. Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV.
Xin KQ; Jounai N; Someya K; Honma K; Mizuguchi H; Naganawa S; Kitamura K; Hayakawa T; Saha S; Takeshita F; Okuda K; Honda M; Klinman DM; Okuda K
Gene Ther; 2005 Dec; 12(24):1769-77. PubMed ID: 16079886
[TBL] [Abstract][Full Text] [Related]
7. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity.
Shiver JW; Fu TM; Chen L; Casimiro DR; Davies ME; Evans RK; Zhang ZQ; Simon AJ; Trigona WL; Dubey SA; Huang L; Harris VA; Long RS; Liang X; Handt L; Schleif WA; Zhu L; Freed DC; Persaud NV; Guan L; Punt KS; Tang A; Chen M; Wilson KA; Collins KB; Heidecker GJ; Fernandez VR; Perry HC; Joyce JG; Grimm KM; Cook JC; Keller PM; Kresock DS; Mach H; Troutman RD; Isopi LA; Williams DM; Xu Z; Bohannon KE; Volkin DB; Montefiori DC; Miura A; Krivulka GR; Lifton MA; Kuroda MJ; Schmitz JE; Letvin NL; Caulfield MJ; Bett AJ; Youil R; Kaslow DC; Emini EA
Nature; 2002 Jan; 415(6869):331-5. PubMed ID: 11797011
[TBL] [Abstract][Full Text] [Related]
8. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.
Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K
Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628
[TBL] [Abstract][Full Text] [Related]
9. Adenoviruses as vectors for HIV vaccines.
Gómez-Román VR; Robert-Guroff M
AIDS Rev; 2003; 5(3):178-85. PubMed ID: 14598567
[TBL] [Abstract][Full Text] [Related]
10. Characterization of transgene expression in adenoviral vector-based HIV-1 vaccine candidates.
Takahashi MN; Rolling JA; Owen KE
Virol J; 2010 Feb; 7():39. PubMed ID: 20163742
[TBL] [Abstract][Full Text] [Related]
11. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
[TBL] [Abstract][Full Text] [Related]
12. Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.
Yu S; Feng X; Shu T; Matano T; Hasegawa M; Wang X; Ma H; Li H; Li Z; Zeng Y
Vaccine; 2008 Nov; 26(48):6124-31. PubMed ID: 18812199
[TBL] [Abstract][Full Text] [Related]
13. Comparison between Sendai virus and adenovirus vectors to transduce HIV-1 genes into human dendritic cells.
Hosoya N; Miura T; Kawana-Tachikawa A; Koibuchi T; Shioda T; Odawara T; Nakamura T; Kitamura Y; Kano M; Kato A; Hasegawa M; Nagai Y; Iwamoto A
J Med Virol; 2008 Mar; 80(3):373-82. PubMed ID: 18205221
[TBL] [Abstract][Full Text] [Related]
14. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
Riezebos-Brilman A; Walczak M; Regts J; Rots MG; Kamps G; Dontje B; Haisma HY; Wilschut J; Daemen T
Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
[TBL] [Abstract][Full Text] [Related]
15. An HIV-based lentiviral vector as HIV vaccine candidate: Immunogenic characterization.
Lemiale F; Asefa B; Ye D; Chen C; Korokhov N; Humeau L
Vaccine; 2010 Feb; 28(8):1952-61. PubMed ID: 20188251
[TBL] [Abstract][Full Text] [Related]
16. Comparative immunogenicity of recombinant adenovirus-vectored vaccines expressing different forms of hemagglutinin (HA) proteins from the H5 serotype of influenza A viruses in mice.
Hu X; Meng W; Dong Z; Pan W; Sun C; Chen L
Virus Res; 2011 Jan; 155(1):156-62. PubMed ID: 20883733
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors.
Shiver JW; Emini EA
Annu Rev Med; 2004; 55():355-72. PubMed ID: 14746526
[TBL] [Abstract][Full Text] [Related]
18. Prime-boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1.
Paris RM; Kim JH; Robb ML; Michael NL
Expert Rev Vaccines; 2010 Sep; 9(9):1055-69. PubMed ID: 20822348
[TBL] [Abstract][Full Text] [Related]
19. Enhanced induction of intestinal cellular immunity by oral priming with enteric adenovirus 41 vectors.
Ko SY; Cheng C; Kong WP; Wang L; Kanekiyo M; Einfeld D; King CR; Gall JG; Nabel GJ
J Virol; 2009 Jan; 83(2):748-56. PubMed ID: 18987146
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus vectors as HIV-1 vaccines: where are we? What next?
DʼSouza MP; Yang OO
AIDS; 2015 Feb; 29(4):395-400. PubMed ID: 25630039
[No Abstract] [Full Text] [Related]
[Next] [New Search]